ICE or TREC? New, less toxic, outpatient salvage regimen.

For those facing ICE as salvage therapy, there is now a less toxic, outpatient regimen available. One of the researchers at Fred Hutchinson was involved in the development of what is being called TREC. It consists of Treanda (Bendamustine), Rituxan, Etoposide and Carboplatin. This recipe is for B-Cell Lymphoma patients. For T-Cell patients, the Rituxan is eliminated, since it does little to nothing against T-Cells. It is preferable because of the lower toxicity, as well as outpatient administration.
For the record, I had a heavily pre-treated and multiple relapsed T-Cell Lymphoma (actually, two slightly different versions simultaneously). There were about two dozen tumors and lymphoma in my small intestine. Now, this is only an anecdote, but two cycles placed me in full response by PET/CT. I went on to have a third cycle and then to transplant. For any who are facing a relapsed or refractory lymphoma, this is certainly a good regimen to discuss with doctor.
Discussion Boards
- 118.9K All Discussion Boards
- 5 CSN Information
- 5 Welcome to CSN
- 118.9K Cancer specific
- 2.7K Anal Cancer
- 421 Bladder Cancer
- 297 Bone Cancers
- 1.6K Brain Cancer
- 28.1K Breast Cancer
- 374 Childhood Cancers
- 27.6K Colorectal Cancer
- 4.5K Esophageal Cancer
- 1.1K Gynecological Cancers (other than ovarian and uterine)
- 12.6K Head and Neck Cancer
- 6.1K Kidney Cancer
- 638 Leukemia
- 759 Liver Cancer
- 4K Lung Cancer
- 5K Lymphoma (Hodgkin and Non-Hodgkin)
- 212 Multiple Myeloma
- 7.1K Ovarian Cancer
- 31 Pancreatic Cancer
- 477 Peritoneal Cancer
- 5K Prostate Cancer
- 1.1K Rare and Other Cancers
- 519 Sarcoma
- 687 Skin Cancer
- 632 Stomach Cancer
- 189 Testicular Cancer
- 1.5K Thyroid Cancer
- 5.6K Uterine Cancer
- 6.2K Other Discussion Boards